Reaction
Genital Herpes reporting signals
As of the last recalculation, Genital Herpes appears in 1,517 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is VALACYCLOVIR HYDROCHLORIDE (PRR 30.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valacyclovir Hydrochloride | 141 | 30.2 | 30.2 |
| Ocrelizumab | 114 | 27.2 | 27.2 |
| Raltegravir | 24 | 20.2 | 20.3 |
| Darunavir | 22 | 20.2 | 20.3 |
| Tiotropium Bromide Inhalation Spray | 13 | 16.0 | 16.1 |
| Abacavir Sulfate | 11 | 15.6 | 15.6 |
| Valacyclovir | 44 | 14.9 | 14.9 |
| Etonogestrel And Ethinyl Estradiol | 21 | 13.2 | 13.2 |
| Phytonadione | 8 | 13.0 | 13.0 |
| Ritonavir | 26 | 12.4 | 12.4 |
| Dolutegravir Sodium | 8 | 12.2 | 12.2 |
| Lamivudine Oral | 22 | 12.1 | 12.1 |
| Lamivudine | 26 | 11.7 | 11.7 |
| Zinc | 20 | 11.3 | 11.3 |
| Sofosbuvir | 16 | 11.2 | 11.2 |
| Zinc Chloride | 20 | 11.2 | 11.2 |
| Efavirenz | 9 | 11.1 | 11.1 |
| Zinc Gluconate | 20 | 10.6 | 10.6 |
| Acyclovir | 69 | 8.6 | 8.6 |
| Brentuximab Vedotin | 6 | 8.1 | 8.1 |
| Fingolimod Hcl | 41 | 6.7 | 6.7 |
| Bendamustine Hcl | 7 | 6.2 | 6.2 |
| Mirabegron | 17 | 6.1 | 6.1 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 18 | 5.5 | 5.5 |
| Botulinum Toxin Type A | 4 | 4.4 | 4.4 |
| Fremanezumab-Vfrm | 3 | 3.6 | 3.6 |
| Diroximel Fumarate | 3 | 3.5 | 3.5 |
| Levonorgestrel | 25 | 1.7 | 1.7 |